Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
ALNY Weekly Chart

Old Forum Content for ALNY

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • woodman: $ALNY has potential.
  • woodman: @jpoko13 $CORT - yeah mentioned it the other day but didn't pull the trigger unfortunately. Others on my list, some of which I do have, were $CPRX $HALO $NBIX $HAE $HRMY $VRTX. Also $ARDX and $ALNY.
  • gmj: $BIIB, $ALNY, $EXEL, $NRIX, $IMGN all wkng abv 50ma today long $BIIB, $LABU tight stops
  • Ajax4Hire: Yes, $MRNA-Moderna(a CoronaVirus vaccine developer) is in the $IBB. Looks like $MRNA, $NVCR and $TECH is the real reason $IBB looks so appealing. Hold% $IBB iShares Nasdaq Biotechnology ETF - Top 15 holdings 7.31% $GILD Gilead Sciences, Inc. 7.13% $AMGN Amgen Inc. 6.02% $VRTX Vertex Pharmaceuticals Incorporated 5.63% $REGN Regeneron Pharmaceuticals, Inc. 4.70% $ILMN Illumina, Inc. 4.62% $MRNA Moderna, Inc. 3.45% $BIIB Biogen Inc. 3.09% $SGEN Seagen, Inc. 2.89% $ALXN Alexion Pharmaceuticals, Inc. 1.90% $INCY Incyte Corporation 1.61% $HZNP Horizon Therapeutics Public Limited Company 1.56% $ALNY Alnylam Pharmaceuticals, Inc 1.52% $BMRN BioMarin Pharmaceutical Inc. 1.26% $NVCR NovoCure Ltd. 1.25% $TECH Bio-Techne Corporation Data from: https://ETFdB.com/etf/IBB/#holdings
  • Ajax4Hire: Bio-Technology; Bio=Life; Techno=art/craft/skill; logy=study of BioTechnoLogy=Life-Craft-Study, aren't we all bio-technologist. Hold% $IBB iShares Nasdaq Biotechnology ETF - Top 15 holdings 7.93% $AMGN Amgen Inc 7.87% $VRTX Vertex Pharmaceuticals Inc 7.45% $GILD Gilead Sciences Inc 6.51% $REGN Regeneron Pharmaceuticals Inc 5.54% $ILMN Illumina Inc 3.37% $BIIB Biogen Inc 3.11% $SGEN Seattle Genetics Inc 2.68% $ALXN Alexion Pharmaceuticals Inc 2.57% $MRNA Moderna Inc 2.43% $INCY Incyte Corp 2.31% $BMRN Biomarin Pharmaceutical Inc 1.83% $ALNY Alnylam Pharmaceuticals Inc 1.38% $SRPT Sarepta Therapeutics Inc 1.24% $NBIX Neurocrine Biosciences Inc 1.21% $SNY Sanofi SA Data from: https://ETFdB.com/etf/IBB/#holdings
  • Ajax4Hire: And the complement; $XBI Bio-Technology; Bio=Life; Techno=art/craft/skill; logy=study of BioTechnoLogy=Life-Craft-Study, aren't we all bio-technologist. Hold% $XBI SPDR S&P Biotech ETF - Top 15 holdings 1.79% $NVTA Invitae Corp 1.60% $INO Inovio Pharmaceuticals Inc 1.48% $NVAX Novavax Inc 1.38% $FOLD Amicus Therapeutics Inc 1.23% $ARWR Arrowhead Pharmaceuticals Inc 1.19% $MNTA Momenta Pharmaceuticals Inc 1.17% $ALNY Alnylam Pharmaceuticals Inc 1.16% $EDIT Editas Medicine Inc 1.15% $SAGE SAGE Therapeutics Inc 1.14% $DCPH Deciphera Pharmaceuticals Inc 1.14% $IMMU Immunomedics Inc 1.14% $KPTI Karyopharm Therapeutics Inc 1.13% $ALKS Alkermes Plc 1.12% $INCY Incyte Corp 1.11% $BMRN Biomarin Pharmaceutical Inc Data from: https://ETFdB.com/etf/XBI/#holdings
  • Herb: $ALNY biotech way up. Must be corona.
  • Reif99: $ALNY start of phase 3?
  • woodman: @Reif99 $ALNY - could be, I hope. I still have it and noticed that the pullback as of yesterday bounced right off old resistance.
  • woodman: $ALNY - flag following move out of lengthy consolidation.
  • woodman: $ALNY - mentioned it last week as it edged out of 2.5 month consolidation at the 50 day. It's breaking out this morning.
  • Hankm: @woodman $ALNY Thanks!
  • Reif99: Some breakouts and some fakeouts today. $COST and $SDC fakeout, $ALNY, $DXCM, $PODD, $RH breakout. $TNDM kind if a breakout out of a sloppy set up. As usual recently, $QQQ leading, $SPY second, $IWM lagging badly
  • champ: @Reif99 $COST $SDC $ALNY $DXCM $PODD $RH $TNDM $QQQ $SPY $IWM --- $SDC, has been doing this daily, pops just about every mornings, see the last 8.
  • woodman: $ALNY edging up out of fairly narrow 2.4 month consolidation with the 50 day having caught up.
  • woodman: @sierramp $ARWR #1 - RNAi biotechs are very much in right now. I have some $ARWR. I'm just holding it unless it collapses. Others, for example, include $ALNY $ABUS $DRNA
  • sierramp: @woodman $ARWR $ALNY $ABUS $DRNA #1 Thanks @woodman. With it moving above the trend line now I did pull the trigger but have a fairly tight stop just to limit risk. I know hope isn't a strategy but hoping it doesn't take out my stop and I'll be able to add higher. The fundies are so good on this stock. I'm having a good day today so either I'm getting smarter or luckier.
  • woodman: @mradams0621 $ABUS $TKMR - RNAi is back in vogue. See $ARWR $ALNY. Also $DRNA (except for today - look out below).
  • Ajax4Hire: @scottrades $IBB IBB iShares Nasdaq Biotechnology ETF 8.57% $AMGN - Amgen Inc 8.12% $GILD - Gilead Sciences Inc 7.55% $VRTX - Vertex Pharmaceuticals Inc 6.27% $ILMN - Illumina Inc 5.15% $BIIB - Biogen Inc 4.75% $REGN - Regeneron Pharmaceuticals Inc 3.47% $ALXN - Alexion Pharmaceuticals Inc 2.88% $SGEN - Seattle Genetics Inc 2.69% $INCY - Incyte Corp 1.95% $BMRN - Biomarin Pharmaceutical Inc 1.75% $ALNY - Alnylam Pharmaceuticals Inc 1.47% $NBIX - Neurocrine Biosciences Inc 1.28% $NVCR - Novocure Ltd 1.27% $MYL - Mylan NV 1.20% $IONS - Ionis Pharmaceuticals Inc 58.4% Top 15 holdings
  • DrScience: $IBB nice volume pushing the Biotechs through the 200 DMA in second day of phase 3 of VS breakout. The 50 DMA starting to turn up, CMF turning positive, and a PPS buy signal on the daily chart. Here are some biotech stocks to research over the weekend, paying special attention to where the stock is and why -- $ARWR $ODT $RARX $RGEN $ZLAB $SRPT $CERS $CLVS $CLDX $CHRS $BLUE $MYRA$ $ALNY $CYTK $ACAD $RGEN $NVTA
  • indigo1948: @DrScience $IBB $ARWR $ODT $RARX $RGEN $ZLAB $SRPT $CERS $CLVS $CLDX $CHRS $BLUE $MYRA $ALNY $CYTK $ACAD $NVTA - thanks for the information - I own $ARWR, $CLVS, and $NVTA. Will research the others.
  • bRobert: $ALNY . tight. So is the $IBB Resolution coming soon. Upward bias. with small down payment. Remaining Balance down with confirmation.
  • bRobert: $ALNY WEEKLY Squeeze breakout. Looking for pullbacks/bounce. More to go out of a weekly squeeze
  • woodman: $ALNY big move.
  • DAN: #Russell 1000 Candidates -- My "bull scan" using the Russell 1000 has kicked out quite a few names. Here's the scan -- which has been explained before: Price > 20 day moving average > 50 day moving average > 200 day moving average...and 200-day moving average is moving higher. Some stocks to watch: $ALNY $ABBV $BURL $LEA (potential breakout) $VLO (potential breakout) $CPA (potential breakout) $JBHT $WYN $LSTR The screen kicked out 155 stocks...which are obviously way too many to post. But the ones above should be watched. Dan
  • Ajax4Hire: @DAN $ALNY $ABBV $BURL $LEA $VLO $CPA $JBHT $WYN $LSTR #Russell So, I'm likin me some $VLO - Valero (an oil refiner). It looks the best of these to invest in right now. Although the Call/Put volume doesn't seem to indicate a direction. Ok, as @Dan said recently; "...not in a stock building mode." I will be patient and watch travel and holiday stocks.
  • CHOFF: @DAN $ALNY $ABBV $BURL $LEA $VLO $CPA $JBHT $WYN $LSTR #Russell I'm curious why you don't have an input for volume in this scan. Any thoughts appreciated.
  • DAN: @CHOFF $ALNY $ABBV $BURL $LEA $VLO $CPA $JBHT $WYN $LSTR #Russell I just don't. No particular reason, other than just wanting to see everything. Also, some of the more illiquid names can also be the biggest movers. I may not trade them...but I at least want to see them so I can make a decision rather than allowing the scan to hide them from me.
  • CHOFF: @DAN $ALNY $ABBV $BURL $LEA $VLO $CPA $JBHT $WYN $LSTR #Russell - Thanks Dan. I wondered as Minervini and Zanger mention how important volume is in their criteria. Instead of a certain threshold of shares traded, I add an input for a % of unusual volume to weed some of them out. It still allows me to see the illiquid names. One problem with the vol input is by the time one sees the high volume trending the move may have already occurred. I suppose we must pick our poison.
  • peppercorn: @Aragorn thanks for these #InsideMonths to consider and track for FEB 2018 - $ADXS $AGCO $AGX $ALNY $ALRM $APT $ATAI $AVAV $BCOV $BLUE $BMRN $CALA $CGNX $CLX $CRTO $DBA $DBD $EFOI $EQT $EYES $GBTC $GLUU $GNC $HQY $IBP $INVE $JJC $KMG $KSU $LAKE $LL $MBI $MDC $MEI $MMC $NTES $OAS $ONCE $ONVO $PAY $PCG $PRTA $PTLA $QRVO $SAIC $SDRL $SFUN $SNAP $SPWR $SWKS $T $TELL $TGI $TRIL $TROV $TROX $USCR $WATT $XOMA $XONE
  • bRobert: $ALNY Nice long sideways consolidation. Weekly with lots of promise. Buy on pullbacks/bounce
  • bRobert: $CELG $CORT $ALNY Nice reversal hammers in a number of quality biotech stocks. CELG holding stock. Easy to get shaken out on multipoint swings in the short term
  • clamtown: @Bridget $XLP $GIS $K $CPB $KHC $XRT $M $KR $COH $XOP $ESV $RIG $MRO $APC $CVE $XLI $XBI $SMH $MCHP $AMAT $AAPL $AVGO $SWKS $ADBE $MLCO $BBBY $BBRY $FDX $FOLD $PX $NOC $TWX $ROP $ALNY $VST $TSG $BEDU $ADNT $SNDR #Notes $AXP You mentioned this one the other day. Any changes.
  • bRobert: $ALNY + .
  • woodman:
  • woodman: @mradams0621 $ABUS - here is the news driving ABUS and $ALNY: http://investor.arbutusbio.com/news-releases/news-release-details/arbutus-lnp-licensee-alnylam-announces-positive-phase-3-0
  • mradams0621: @woodman $ABUS $ALNY Thank you for the fish. Wish I could learn to fish for myself. Any secrets you would be willing to share? How did you find that info?
  • woodman: @mradams0621 $ABUS $ALNY - the company's website (press releases). Also found on Twitter which is an excellent resource. Always look there for news.
  • mradams0621: @woodman $ABUS $ALNY Thank you kind sir
  • Bridget: #Notes $XLP - these consumer products were down on $GIS earnings $K $CPB $KHC $XRT - retail stocks falling lower $M $KR $COH $XOP - oil performing well. Good liquid stocks $ESV $RIG $MRO $APC $CVE $XLI - hit new highs $XBI - close to breaking higher out of flag $SMH - this rally is fizzling $MCHP $AMAT $AAPL - broke support at he 50dMA, $AVGO $SWKS - breaking down $ADBE - struggling to hold trendline after earnings $MLCO - gapped up this morning but then sold off $BBBY - hit a new low after earnings Breakouts $BBRY $FDX $FOLD $PX $NOC $TWX $ROP $ALNY IPOs working $VST $TSG $BEDU $ADNT $SNDR
  • bRobert:
  • Bridget: @bRobert $XLP $GIS $K $CPB $KHC $XRT $M $KR $COH $XOP $ESV $RIG $MRO $APC $CVE $XLI $XBI $SMH $MCHP $AMAT $AAPL $AVGO $SWKS $ADBE $MLCO $BBBY $BBRY $FDX $FOLD $PX $NOC $TWX $ROP $ALNY $VST $TSG $BEDU $ADNT $SNDR #Notes I agree that this is likely just a pause, not a top.
  • Bridget: $ALNY is breaking down from its uptrend. Will likely pullback to the 50dma.
  • ROSEY: @gwenzee $BLUE Thanks for this post @gwenzee. Are you also watching $ALNY?
  • gwenzee: @ROSEY $BLUE $ALNY Have a position in BLUE. Don't follow ALNY.
  • Bridget: Notes: $XLU in a downtrend on the daily now $UNG new 52 week low $BHI - big move after this downtrend, special dividend on 7/7 $AAP $AZO $ORLY - down big on warning $CBOE - new all time high $CX - breakout $CNC - good buy point in this uptrend $CCL $RCL - steady uptrend $BZUN - nice breakout $AABA - steady uptrend IBB XBI - many healthcare stocks looking well today $CALA - breakout $ACHC - higher highs $ALNY - nice uptrend
  • woodman: $XBI - I had hoped it wouldn't be the case, but it's taking it on the chin today. Perhaps coincidentally occurring with $ALNY's collapse, but maybe not if folks are now skeptical on the entire RNAi platform. Too early to say that, though. But see $IONS, e.g.
  • issues: @bwcarnation1 $SWKS Right! Tank it will since you own it. Just kidding. I feel the same way especially when you look at $ALNY!
  • issues: @woodman $XBI $ALNY $IONS Good points. We continue to patiently hold $IBB and $IONS. The product line and research in IONS looks great to me. We are long term holders of these. But the ones we are disappointed with (but still holding) are $GILD and $VRX $VRTX $JAZZ. Doing well with $CBPO and $ABMD. That $WBMD (also holding) seems like it's turning around.
  • woodman: $ALNY - bad news for this one. May affect all Rnai companies, including $ARWR $IONS ... http://endpts.com/deaths-force-alnylam-to-scrap-its-no-2-drug-in-phiii-development/
  • woodman: $ALNY $ARWR $IONS - I'm wondering if this will affect biotech tomorrow. $IONS is about 3% of $XBI.
  • woodman: @woodman $ALNY $ARWR $IONS $XBI - List of RNAi companies. Example 5,429 to make you wonder why we hold biotechs. Pass the smelling salts! http://biopharmguy.com/links/company-by-location-dna-rna.php http://biopharmguy.com/links/company-by-location-dna-rna.php
  • osgood: @woodman $ALNY $ARWR $IONS Amyloidosis (although it was primary AL, not the hereditary version) killed my best friend in 2010. It is an absolute killer disease.
  • woodman: @Alexandra $NTLA - Thanks for providing your work. I'd forgotten about this one. I mentioned it in August and briefly traded it thinking it was done going down at that time. I was wrong and sold my position not long after buying it. I don't think ...
  • Aragorn: $ALNY daily hammer up off the 8ema watch this one $IP breaking out of consolidation expanding the bollingers
  • StockMarketMentor: A Price Alert has been triggered for $ALNY Alnylam Pharmaceuticals Inc.. Click here to view associated video clip: http://stockmarketmentor.com/stockanalysis.html?ticker=ALNY&clip=69155
  • Kid2old: @Aragorn $AAL $ADBE $ADRO $ALK $ALNY $AMZN $APA $ASPS $ATI $ATVI $BIB $BIDU $BMY $CA $CAKE $CANF $CBRL $CBS $CEMP $CENX $CMG $COG $COR $CORE $COST $CRM $CSX $CTL $CTRP $CTSH $CVLT $DATA $DIS $DPLO $DRI $DSX $EAT $EBAY $EQIX $EXPE $FBIO $FDX $FOLD $FRSH $FTI $GOOG $GOOGL $GWW $HERO $HLF $IBB $ILMN $INSY $IP $ITB $JBHT $JUNO $KMI $LAKE $LJPC $LL $LNKD $LOCO $LOW $LVLT $LVS $MLNX $MSFT $MXL $MYGN $NDAQ $NDLS $NOC $NTES $NVDA $ONVO $ORCL $PM $QLD $QQQ $R $RAX $RDUS $RENN $RH $RL $RMBS $RWLK $SAVE $SDRL $SGY $SINA $SLCA $SU $SVXY $SWHC $SWN $SYNA $TASR $TDW $TQQQ $TREX $TROV $TSCO $TSLA $UA $ULTI $UTX $UVXY $V $VA $VISN $VIXY $VRX $VXX $WHR $WY $XHB $XIV $XLK $XLY $XOMA $XONE
  • Aragorn: $ALNY continuing move up near HOD $EDIT going for the gold
  • TRICIA: ...
    $ALNY upgraded to Overweight from Neutral by JP Morgan. Price target lowered to $81 (37% upside) from $111.
    $FOLD upgraded to Buy from Neutral by Janney Capital. Price target raised to $12 (59% upside) from $10.

    $PTX downgraded to Market Perform ...
  • Bridget: $ALNY coming out of a squeeze
  • woodman: @gwenzee $GILD $INCY $ICPT, etc. I've seen the following names recently bandied about as a $GILD acquisition: $MDVN $ALNY $INCY $BMRN $BXLT $VRTX.
  • TRICIA: $TKMR, $ALNY, $ARWR --- Vienna - European Liver Meeting HEPB ..also NASH -- ICPT, CNAT, GNFT, .... and HEP C ... GILD, GILD, ... ABBV, MRK .. #EASL15 ---go there on twitter and read up .. I 'll answer questions later ALso BLUE, SGMO ... but I told you these were the strongest of the CARt's 2 night ago ... trades for a few days make money too so I offer tickers that do both ... I went long on several tickers going into EASL and AAN and AACR .... back to class but awesome news from several meetings ..get your notebook and write down key dates etc ..
  • woodman: $TKMR - this is good news not just for $ALNY but also $TKMR. It (further) validates TKMR's platform which ALNY uses. http://finance.yahoo.com/news/alnylam-reports-12-month-clinical-100000838.html
  • TRICIA: #RNAi tickers .. $ARWR - fake sell off ... watch volume, the stock is 26% short and after buying back RNAi tech from NVS a few weeks ago, they are very promising .. Watch $TKMR, $MRNA, $ALNY etc ... (watching not buying)..
  • TRICIA: #RNAi tickers .. late afternoon pop in $ARWR, also $SRPT, even $TKMR and $ALNY checking for news but none is jumping except there was a lot of call activity in $ARWR in late afternoon
  • TRICIA: #RNAi tickers of interest .. $ARWR ( it picked up $NVS discarded RNAi tech for $35 M..... $ALNY's CEO is pissed off and said so (this guy is a schoolyard bully!) .. $ALNY gave it back to $NVS ... Oh the tangled webs .... $ARWR ...$ARWR Acquires Novartis’ RNAi Research and Development Portfolio. https://finance.yahoo.com/news/arrowhead-acquires-novartis-rnai-research-123000620.html …
  • dkoran: $ALNY- price target $160 defended today.
  • TRICIA: $ALNY, $AGRX, $NERV, $VSTM, $KERX, $PBYI, $XON, $ARNA and $VTAE, $ZFGN --- offerings all --- cash raising ... the list is growing .... #SHELFS, #OFFERINGS
  • SmallDogTrade: ...
    Sometime I'll buy LEAPS which is also not a half bad idea. I've done well using LEAPs on $ALNY The spreads are wide, so I wait for a crushing day to put those on.
  • mflo6952: $ALNY - Potential low risk buy at support following earnings yesterday
  • TRICIA: $TKMR Tekmira Pharma reports Q3 results (15.90 0.78) Q3 EPS (C$0.39) vs (C$0.28) Capital IQ Consensus; revs C$4.4 mln vs C$4.46 mln Capital IQ Consensus Estimate In response to the extremely unique circumstances surrounding the Ebola virus outbreak, we have designed and initiated production of a modified RNAi therapeutic directed against the Guinea variant of the Ebola virus, which is responsible for the epidemic in West Africa. We are also very pleased that the DoD exercised the option to manufacture TKM-Ebola-Guinea, valued at $7.0 million. This shows a commitment to the continued development of anti-Ebola therapeutics." The Company announced it will be hosting an Analyst Day on November 21 at the Le Parker Meridien in New York Expect news this weekend re HBV Expect to hit my PT of $37 ... then $40. Expect to hear Nov 21 collaborations with others ...like $ALNY
  • TRICIA:
  • TRICIA: #AASLID2014 - IT's all about LIVER ..(hideous childhood memory - Mom making LIVER and Onions omg -- gag me :-( Nov. 7-11: American Association for the Study of Liver Disease (AASLD): #NASH $GILD, $CNAT, $ICPT, $GALT, $GLMD, $ALGFT $ALNY,$MDCO $ACHN #HEPC $GILD, $$BMY, $MRK, $ABBV, $ENTA, $RGLS, .. $ACHN no show> re it's NUC? #HEPB $ARWR, $TKMR, $ALNY, $CELG $GILD, $GBIM, $TLOG Looking at these companies, & considering the money being poured into all these very very expensive trials --I'm thinking this is a make or break weekend May we need a LIVER ETF - Call it $GAG (from the Mommy dearest chronicles) Feuerstein posed these questions .. http://adamfeuerstein.tumblr.com/post/101757154622/five-burning-questions-liver-disease-stocks FD - Long GILD, ENTA, TKMR, CNAT, GBIM - I will be in Boston this weekend as a guest of some bio - analysts ...excited to meet them and maybe look for a job.
  • TRICIA: $TKMR @wildfire3d -price target is $37 /share ... Current #Ebola work = $4.00 of that. If awarded the #EBOLA stockpiling contract .. you can add another $3.00 or $40.00/ ahare. The LNP Tech drug delivery system (currently a success with $ALNY success ) is a core strength - just hard to see clearly with #EBOLA. The TAM for HEP B is bigger than HEP C perhaps 2.5 times!) $ARWR was the leader but they wobbled a bit ... okay alot!. AASLID in Boston this weekend will be interesting and I toyed with buying some back this morning ..there is always tomorrow.
  • woodman: $TKMR/$ALNY - I know many here still just view TKMR as an Ebola company and just "one of the Ebola stocks." However, I have posted over at least a couple weeks now that despite the all the Ebola stock traders' narrow views, TKMR doesn't wa ...
  • TaxFish: $ALNY $SPLK : I like the platform these stocks are building with tight consolidation. Anyone have any thoughts on these?
  • Aragorn: $ALNY inside day and up
  • Tricia: RNAI therapies are still delivering.. $TKMR: ↑9% I suspect CEO wants more gov't money for this drug, and indemnification b/c we still don't know enough about possible A/E's. Also protocol needs to be established - "Who" gets the drug? Chaos and fear are the rule in W Africa and WHO is NOT on First ... in fact these idiots are not in the damn game #EBOLA HEP B is a very viable story -- REAL STORY - remains LPN technology ... LPNT Analogy Question? ADC:$SGEN as LNPT:$TKMR ... True or False ARWR: ↑ 6% HEP B leadership for now .. Long ARWR, Overly - LONG TKMR. also tiny watching positions in $ALNY, $MRNA
  • Tricia: $TKMR, $ARWR, $ALNY, $GILD - HEP B .. From this weeks conf calls $ARWR is first in line with successful knockdown of virus $TKMR - may emerge the victor b/c LPN technology eliminates pre-treatment $ALNY - brings up the rear for the RNAi based HBV treatments $GILD - would not be surprised to see them buy one of the above- they know how to exploit opportunities ...they know anti-virals ...... Actions: Nov 8th Liver Conference Boston - HEP B is the focus Buy TKMR this am @16.8 - back to 1/3 position - will add on dips Long ARWR - full Long GILD - "shocking isn't it ... lol Watching ALNY - will buy at support .. (should have bought Mon - doh)
  • Tricia: ...
    Other companies have products that WILL NOT WORK without this proprietary LPN tech. $ALNY is a good example - it has late stage pIII trials with data due in 4Q 2014 and also for 3 more in Phase 1/2 trials. That is big money for both companies.

    2) ...
  • Tricia: #BIOTECH EArnings week - 44 This Week! EArnings Mon 08/11 incl: $MACK $INO $AKBA $BLUE $RYLP $ENTA $PBYI $HALO (26 Today) Earnings Tues 08/12 incl: $INSY $BCRX $ARRY $RNA $PETX $STEM $ARWR (13) Earnings Wed 08/13 incl: $EPZM $CNAT $ONTX $TKMR There is a lot of data this week also .. should be very interesting $EPZM data at ASH Lymphoma meeting on August 12 $OPK will have top-line Rayaldee data on Monday night as well. Hep B Updates from $ARWR, $TKMR -- $ALNY will have another roundtable with $MDCO
  • Tricia: #HEP B ....4.5 years ago we created the HEPC 7 ... IDIX and ACHN were leaders and GILD wa just an upstart who overpaid for Pharmasset ... By now it should be obvious that I halo a disease and look at the potential of companies with a stake in that area of disease management. The SMM/OMM HEP B are $ARWR, #TKMR, $GILD, $ALNY treatments and $DVAX, $GSK - vaccines I will set up a FINVIZ tracker .. THere is data expected from ARWR ad TKMR next week for ongoing clinical trials in HEP B ......RHRN ..ARWR is the lead ... but that can change .... Why should you care?.... TAM for HEPB is 2.5x's the TAM for HEPC .... hmmm Stay tuned
  • Tricia: #EBOLA - new stories AH .. I urge you to wait for confirmation ... and CNN has been wrong ao I am not sure about the claim this morning. Doesn't matter , what matters is what the market believes...SOOOOOOO I did buy back just under !3.00 .. I wanted to have a tranch in place. I may regret not buying more, and if Tekmirs gets the FDA hold lifted we are looking at $20 ... and if $ALNY and $SPPI give out top line results(they have to use $TKMR's patented delivery (LPNT) ... another ares for $TKMR to shine. If you are wondering ... we did not hear from $TKMR management as it is a national holiday in Canada Any news please post and we can investigate .. HAve a good night
  • Tricia: SMM RNAi Tickers - $ALNY, $ARWR, $TKMR ON WATCH RHRN $ALNY - HepB Presents today, $ARWR - HepB on CNBC ysterdy , $TKMR #Ebola from our SMM/OMM RNAi based Therapies in development ALNY,ARWR,DRNA,MRNA,TKMR,RXII,SLN.L,BLT.AX,ISIS,RGLS,RSGN,SRPT,RNA,RGDO,PTCT,RNA,BLUE http://elite.finviz.com/screener.ashx?v=151&t=ROSG,ALNY,ARWR,DRNA,MRNA,TKMR,RXII,SLN-L,BLT-AX,ISIS,RGLS,RSGN,SRPT,RNA,RGDO,PTCT,RNA,BLUE&o=-perfytd
  • Tricia: $ALNY: presents Hepatitis B VIRUS (HBV) I will be watching $ALNY #RNAi Roundtable: ALN-HBV for the treatment of #HBV Tuesday, July 29: 9:30 – 10:30 a.m. ET Check on7/22 for last update There is speculation that $ARWR was trying to steal thunder re HBV ....
  • Tricia: $ALNY: attended the roundtable this morning as indicated last night ---The company reviewed its progress with ALN-HBV in development for Hepatitis B Virus (HBV)

    Who else is working on Hep B - $ARWR - @Gwenzees's new cabana boy turned CEO was on CNB ...
  • Tricia: @debeers $TKMR - hey long time no see ... hope things are well! Ditto what you wrote... I would add 3 things 1) Department of Defense Contract (USDOD) 2) Delivery technology (LNPT) is being used by other Companies in their PHASE III trials ..... $ALNY has 2 p3s going on rhrn. ( 3) In the human trial - ONLY 1 participant had a cytokine reaction and that was the high dose .....I believe we will see this resolved b4 Dec 4) EBOLA (700 are dead - a lead Dr has died and latest news shows 2 more young MD's and 4 nurses are now infected. One of those MD's is Kevin Brantly from TExas ... As I sit here and read up in getting lily beetles off my Casa Blanca's .... I am so grateful for my health and for my friends (includes all the forum) and their families ..... it gives me pause and gratitude. Have a great week everyone ... Nugget sends his paws!
  • Tricia: SMM RNAi Tickers $ARWR - In PR for unrelated patent, $ALNY claims to own/have licensed UNA delivery technology #Arcturus $ARWR $MRNA $TKMR http://www.nasdaq.com/press-release/alnylam-receives-notice-of-allowance-from-united-states-patent-and-trademark-office-uspto-for-new-20140722-00354 … last week Jeffreies - presentiation http://wsw.com/webcast/jeff82/arwr/ … Janet Yellin's comments gave several entries to small but good small cap bios ...
  • Tricia: ...
    My thoughts on 072214 $ALNY RNAi Roundtable:

    What stood out to me:
    1. RE: siRNA pre-clinical studies: “ . . . excellent correlation between non-human primates and humans . . .”
    2. RE: GalNac targeted siRNA “ . . . meant to be a mu ...
  • Tricia: @SierraJW $ARWR - the low was first week of May .. it got clobbered when $ALNY claimed patent infringement .. appears $ALNY may be wrong ..
  • Tricia: FAST Money just a a biotech analyst on - her recommendations BIG CAP Biotech ... $BIIB ... why? MS drug .. it could move 30 to 100 dollars before year end .... (8 - 25% move) Mid Cap - $TSRO - an ASCO candidate for ovarian CA and finally $ARWR( stating this company will has the cure for HEPB ...maybe - $ALNY has claims on patents and there are 5 other companies working on HEP B .. ARWR is up a buck AH ... She does not cover several stocks that I think may be equal to the task --- ie GILD, ILMN,PCYC CLVS, CLDX ...etc... I hold a bit of BIIB, and 1/4 position of ARWR --- RNAi's have been hard hit ...
  • Tricia: $ALNY:(a Dan favorite- j/k) ... elects lawyer to its Board of Directors. I wonder why.... http://finance.yahoo.com/news/alnylam-elects-amy-schulman-board-120000332.html … These patent disputes are creating some of the waves in the RNAi space ....affects $ARWR in the HepB space...
  • Tricia: RNAi therapies continue to recover from last Friday...as I posted first thing Monday, Fridays' patent bullying from from $ALNY was a big buy opp .. $TKMR, $ARWR, $RNA, and even that penny ticker $MRNA ..
  • Tricia: RNAi tickers and patent wars - $TKMR ( hod) marches back toward $15 and $ARWR does too ... not so fast ALNY ... As advised the other morning .. $ALNY doesn't have the power they think and $ARWR, $TKMR are coming back from Friday's blow off (buy opp) .. HBV is a worldwide problem .... $ALNY's patents are only in the US and further, they did sign agreements with Arrowhead ...you can read more about these on Twitter .. http://www.cnbc.com/id/101715269
  • Tricia: $TKMR,$ALNY,$ARWR - Patent Wars .... $ALNY is making some strong claims ...I am out of both ALNY and ARWR until we get more clarity .... $TKMR ... buying premarket .. -EBOLA ... it is not over! Friday's hideous selloff is a buy for me .... not about charts for me .. this is about world news ...
  • Tricia: @Tricia $ARWR, $ALNY ---- Arrowwood may NOT be affected overseas by ALNY's patent claim ... just US in question ... HBV another world wide problem .. $ARWR .. may buy into this morning ..
  • Tricia: @Tricia $ARWR $ALNY DB: "take on ARWR patent related weakness.. pic.twitter.com/PSiBmlVaVy
  • BocaRick: @chuckd $TKMR if you check twitter $TKMR you will see a lot of postings on the $ALNY $TKMR legal and patent activity?
  • woodman: #RNA stocks on fire: $ARWR, $TKMR, $ALNY.
  • woodman: $ALNY - popping now. I bought this back this morning around where I got shaken out recently. (Bought back more than I sold.) Looks like it's putting in higher lows and highs and seeing some rising support. If it can just get and stay above the 200 day, there is room to run.
Visit the Trading Forum to join in the discussion.
Stock Price $149.45
Change -3.20%
Volume 666,574

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.

Request Video of ALNY
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!